| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 02/19/1997 | CN1143366A 4-amino derivatives of mycophenolic acid |
| 02/19/1997 | CN1143363A Isoxazoline compounds as inhibitors of TNF release |
| 02/19/1997 | CN1143319A Compound and methods for treatment of cardiovascular, inflammatory and immune disorders |
| 02/19/1997 | CN1143075A 15-deoxyspergualin analogs, their method of preparation and their use in therapeutics |
| 02/19/1997 | CN1142973A Vaccine composition having antitumour activity and use thereof in therapy of malignant diseases |
| 02/19/1997 | CN1034077C Preparation of new pyrido|2,3-f¨|1,4¨ thiazepines |
| 02/18/1997 | US5604261 Having hydroxyl/alkoxyl group ortho to amide group on phenyl ring; high melatonin receptor affinity |
| 02/18/1997 | US5604247 Chromone Derivatives |
| 02/18/1997 | US5603951 Cyclosporin-containing soft capsule compositions |
| 02/18/1997 | US5603943 Physiologically active substance homogeneously dispersed in and adsorbed on polyvalent metal carrier of specified particle size |
| 02/18/1997 | US5603937 Immune-enhancing food comprising isaria type insect raised fungus (cordyceps japonensis) as a main ingredient |
| 02/15/1997 | CA2183048A1 Substituted 4h-pyrans |
| 02/13/1997 | WO1997005267A2 Mucosal delivery of polynucleotides |
| 02/13/1997 | WO1997005239A1 Autologous immune cell therapy: cell compositions, methods and applications to treatment of human disease |
| 02/13/1997 | WO1997005169A1 Ha-2 antigenic peptide |
| 02/13/1997 | WO1997005168A1 The h-y antigen |
| 02/13/1997 | WO1997005105A1 N-(aroyl)glycine hydroxamic acid derivatives and related compounds |
| 02/13/1997 | WO1997004808A1 Compositions containing analgesics and antihistamines and methods for treating respiratory disorders |
| 02/13/1997 | WO1997004802A1 Isolation and/or preservation of dendritic cells for prostate cancer immunotherapy |
| 02/13/1997 | WO1997004779A1 Quinolones and their therapeutic use |
| 02/13/1997 | WO1997004775A1 Quinolones and their therapeutic use |
| 02/13/1997 | WO1997004768A1 Non-ionic surfactant vesicles as therapeutic agent |
| 02/13/1997 | WO1996034969A3 Gene therapy using replication competent targeted adenoviral vectors |
| 02/13/1997 | WO1996002240A3 Use of inhibitors of human s-cd23 |
| 02/13/1997 | CA2228298A1 Non-ionic surfactant vesicles as therapeutic agent |
| 02/13/1997 | CA2228176A1 Isolation and/or preservation of dendritic cells for prostate cancer immunotherapy |
| 02/13/1997 | CA2227958A1 Compositions containing analgesics and antihistamines and methods for treating respiratory disorders |
| 02/13/1997 | CA2227871A1 Mucosal delivery of polynucleotides |
| 02/13/1997 | CA2227327A1 Autologous immune cell therapy: cell compositions, methods and applications to treatment of human disease |
| 02/13/1997 | CA2225555A1 Quinolones and their therapeutic use |
| 02/13/1997 | CA2225552A1 Quinolones and their therapeutic use |
| 02/13/1997 | CA2224909A1 Ha-2 antigenic peptide |
| 02/13/1997 | CA2224894A1 The h-y antigen |
| 02/12/1997 | EP0758021A2 Method for determining the therapeutic activity of metalloproteinase inhibitor compounds, new inhibitor compounds, and the therapeutic use thereof |
| 02/12/1997 | EP0757718A1 Methods of use of uncoated gel particles |
| 02/12/1997 | EP0757557A1 Methods for inducing t cell tolerance to a tissue or organ graft |
| 02/12/1997 | EP0564588B1 Hexapeptide anaphylatoxin-receptor ligands |
| 02/12/1997 | CN1142855A Humanized antibodies and uses thereof |
| 02/12/1997 | CN1142854A C5a receptor antagonists having substantially no agonist activity |
| 02/12/1997 | CN1142827A HIV protease inhibitors |
| 02/12/1997 | CN1142819A Morpholine and thiomorpholine tachykinin receptor antagonists |
| 02/12/1997 | CN1142817A 1N-alkyl-N-arylpyrimidinamines and derivatives thereof |
| 02/12/1997 | CN1142499A Tricyclic 5,6-dihydro-9H-pyrazolo|3,4-c¨-1,2,4,-triaolo (4,3-alpha¨ pyridines |
| 02/12/1997 | CN1142493A Arylalkylpyridzinones |
| 02/12/1997 | CN1142382A Prescription of health-care restorative spirit and production thereof |
| 02/12/1997 | CN1142360A Medical composition for treating burn and scald without scars |
| 02/12/1997 | CA2183020A1 Activated immunoglobulin |
| 02/11/1997 | US5602275 May be used to accelerate recovery from neutropenia accompanying radio- or chemotherapy, bone marrow transplantation or infections |
| 02/11/1997 | US5602173 Inhibit phosphodiesterase activity, tumor necrosis factor production |
| 02/11/1997 | US5602157 Compounds useful for treating allergic and inflammatory diseases |
| 02/11/1997 | US5602147 Piperidinyl thiacyclic derivatives |
| 02/11/1997 | US5602132 Branched-amino-substituted thiazoles, processes for their preparation and the pharmaceutical compositions which contain them |
| 02/11/1997 | US5602109 Feeding human infant dietary formula that alleviates diarrhea; contains ribonucleotides |
| 02/11/1997 | US5602099 δ opioid receptor antagonists |
| 02/11/1997 | US5602007 Recombinant DNA molecules |
| 02/11/1997 | US5601821 Histamine releasing peptide |
| 02/11/1997 | US5601799 Glycoprotein has affinity to macrophages, useage as drug delivery |
| 02/11/1997 | CA2045605C Treatment of leukocyte dysfunction with gm-csf |
| 02/11/1997 | CA2034546C 1, 3-dicarbonyl compounds and their use |
| 02/06/1997 | WO1997004118A1 Cd4 gene regulatory sequences specifically expressed in mature t cells |
| 02/06/1997 | WO1997004109A1 α-β C4BP-TYPE RECOMBINANT HETEROMULTIMERIC PROTEINS |
| 02/06/1997 | WO1997004097A2 Human ctla-8 and uses of ctla-8-related proteins |
| 02/06/1997 | WO1997004093A1 Nucleotide and peptide sequences for treating myasthenia |
| 02/06/1997 | WO1997004085A1 Autoreactive peptides from human glutamic acid-decarboxylase (gad) |
| 02/06/1997 | WO1997004004A1 CYSTEINE PROTEASE INHIBITORS FOR USE IN TREATMENT OF IgE MEDIATED ALLERGIC DISEASES |
| 02/06/1997 | WO1997004000A1 Hepadnavirus receptor |
| 02/06/1997 | WO1997003951A1 Esters and amides as pla2 inhibitors |
| 02/06/1997 | WO1997003703A1 Adeno-associated viral liposomes and their use in transfecting dendritic cells to stimulate specific immunity |
| 02/06/1997 | WO1997003695A1 Methods for detecting, identifying, isolating, and selectively labelling and targeting th1 lymphocytes by means of the lag-3 protein |
| 02/06/1997 | WO1997003687A1 SOLUBLE LYMPHOTOXIN-β RECEPTORS AND ANTI-LYMPHOTOXIN RECEPTOR AND LIGAND ANTIBODIES, AS THERAPEUTIC AGENTS FOR THE TREATMENT OF IMMUNOLOGICAL DISEASE |
| 02/06/1997 | WO1997003686A1 Tnf receptor and steroid hormone in a combined therapy |
| 02/06/1997 | WO1997003680A1 Transferrin glycans composition for the induction of immune tolerance |
| 02/06/1997 | WO1997003664A1 Use of ipriflavone to reduce the number of cd8+ cells |
| 02/06/1997 | WO1997003654A2 Pharmaceutical compositions |
| 02/06/1997 | WO1997003653A1 Enterogenin pharmaceutical form |
| 02/06/1997 | WO1996036324A3 Use of a pharmaceutically acceptable oxalate derivative in the manufacture of a medicament for the treatment of skin conditions |
| 02/06/1997 | CA2227477A1 Soluble lymphotoxin-.beta. receptors and anti-lymphotoxin receptor and ligand antibodies, as therapeutic agents for the treatment of immunological disease |
| 02/06/1997 | CA2227466A1 Esters and amides as pla2 inhibitors |
| 02/06/1997 | CA2227441A1 Hepadvavirus receptor |
| 02/06/1997 | CA2227421A1 Use of ipriflavone to reduce the number of cd8+ cells |
| 02/06/1997 | CA2227334A1 Methods for detecting, identifying, isolating, and selectively labelling and targeting th1 lymphocytes by means of the lag-3 protein |
| 02/06/1997 | CA2227220A1 Human ctla-8 and uses of ctla-8-related proteins |
| 02/06/1997 | CA2227198A1 Cysteine protease inhibitors for use in treatment of ige mediated allergic diseases |
| 02/06/1997 | CA2227065A1 Adeno-associated viral liposomes and their use in transfecting dendritic cells to stimulate specific immunity |
| 02/06/1997 | CA2227035A1 Cd4 gene regulatory sequences specifically expressed in mature t cells |
| 02/06/1997 | CA2227030A1 .alpha.-.beta. c4bp-type recombinant heteromultimeric proteins |
| 02/06/1997 | CA2226879A1 Transferrin glycans composition for the induction of immune tolerance |
| 02/06/1997 | CA2200295A1 Enterogenin pharmaceutical form |
| 02/05/1997 | EP0756827A2 Composition for nutrition |
| 02/05/1997 | EP0756629A1 Pharmaceutical formulations for treating japanese cedar pollen allergy |
| 02/05/1997 | EP0756605A1 Peptides as therapeutic agents for the treatment of auto-immune diseases |
| 02/05/1997 | EP0756604A1 Melanoma antigens |
| 02/05/1997 | EP0756603A1 Multirepresentation of a peptide analogue of the dppiv substrate, especially of the kpr type, to inhibit the entry of hiv in cells |
| 02/05/1997 | EP0756595A1 Substituted 1,3-oxathiolanes with antiviral properties |
| 02/05/1997 | EP0756492A1 Use of g-csf to reduce acute rejection |
| 02/05/1997 | EP0756489A1 Cyclosporin containing composition and process for the preparation thereof |
| 02/05/1997 | CN1142227A Novel thiazolidin-4-one derivatives |
| 02/05/1997 | CN1142222A Diesters of carbonic acid endowed with antiviral and anti-inflammatory activity |
| 02/05/1997 | CN1141921A Chromone derivative |
| 02/04/1997 | US5599905 Interleukin-4 receptors |